ロード中...
Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
INTRODUCTION: Abnormalities in lipid metabolism may contribute to the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Fenofibrate induces early and reversible reduction in estimated glomerular filtration rate (eGFR), but it may have protective effects on...
保存先:
| 出版年: | Kidney Int Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308372/ https://ncbi.nlm.nih.gov/pubmed/30596172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.09.006 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|